You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
歸創通橋-B(02190.HK)預計中期收入大增3102%至3292%
格隆匯 08-02 19:28

格隆匯8月2日丨歸創通橋-B(02190.HK)發佈公吿,公司預期截至2021年6月30日止六個月的未經審計收入總額將約人民幣6750萬元至人民幣7150萬元,較2020年同期的收入總額約人民幣210.8萬元(未經審計)增加3,102%至3,292%。

收入總額增加,主要由於:(i)自2020年6月30日至今,公司已從國家藥品監督管理局取得八種產品的批准,其中截至2021年6月30日,公司已在中國成功推出六種產品。該等已上市的產品主要包括蛟龍顱內取栓支架、UltrafreeTM藥物洗脱PTA球囊擴張導管、顱內支持導管及顱內球囊擴張導管,貢獻截至2021年6月30日止六個月的收入總額超過85%;(ii)於2020年6月30日之前批准的產品(包括PTA球囊擴張導管)截至2021年6月30日止六個月產生的銷售收入,與2020年同期比較增加超過300%;及(iii)透過廣泛的分銷網絡,公司在中國進行的產品商業化已取得重大進展,已覆蓋超過1,500家醫院。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account